Beck Belinda R
School of Allied Health Sciences, Griffith University, Gold Coast, QLD, 4222, Australia.
Curr Osteoporos Rep. 2015 Dec;13(6):381-9. doi: 10.1007/s11914-015-0294-8.
A considerable volume of evidence has accumulated to suggest that whole-body vibration (WBV) may have a therapeutic role to play in the prevention of osteoporotic fracture, particularly for individuals who are unable to tolerate vigorous exercise interventions. There is moderate to strong evidence that WBV will prevent falls (likely due to enhanced neuromuscular function), but also some indication that the effects of WBV do not outstrip those of targeted exercise. Animal data indicates that WBV will also improve bone mass, including preventing loss due to hormone withdrawal, disuse and glucocorticoid exposure. Human trials, however, have produced equivocal outcomes for bone. Positive trends are apparent at the hip and spine, but shortcomings in study designs have limited statistical power. The mechanism of the vibration effect on bone tissue is likely to be mechanical coupling between an oscillating cell nucleus and the cytoskeleton. More robust dose-response human data are required before therapeutic guidelines can be developed.
大量证据已积累表明,全身振动(WBV)在预防骨质疏松性骨折方面可能具有治疗作用,特别是对于无法耐受剧烈运动干预的个体。有中度至强有力的证据表明WBV可预防跌倒(可能是由于神经肌肉功能增强),但也有一些迹象表明WBV的效果并不超过针对性运动的效果。动物数据表明,WBV还可改善骨量,包括预防因激素撤减、废用和糖皮质激素暴露导致的骨量流失。然而,人体试验对骨骼的结果并不明确。在髋部和脊柱有明显的积极趋势,但研究设计的缺陷限制了统计效力。振动对骨组织的作用机制可能是振荡的细胞核与细胞骨架之间的机械耦合。在制定治疗指南之前,需要更可靠的人体剂量反应数据。